HCV-IN-30

CAS No. 1007882-23-6

HCV-IN-30( —— )

Catalog No. M26246 CAS No. 1007882-23-6

HCV-IN-30 is an HCV NS5A replication complex inhibitor (IC50s: 901 and 102 nM for genotypes 1a and 1b replicons).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
25MG 36 In Stock
50MG 54 In Stock
100MG 87 In Stock
200MG Get Quote In Stock
500MG 230 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HCV-IN-30
  • Note
    Research use only, not for human use.
  • Brief Description
    HCV-IN-30 is an HCV NS5A replication complex inhibitor (IC50s: 901 and 102 nM for genotypes 1a and 1b replicons).
  • Description
    HCV-IN-30 is an HCV NS5A replication complex inhibitor (IC50s: 901 and 102 nM for genotypes 1a and 1b replicons).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CDK1/CyclinB| Cdk5/p25| GSK-3β
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1007882-23-6
  • Formula Weight
    624.77
  • Molecular Formula
    C36H44N6O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 20 mg/mL (32.01 mMul)
  • SMILES
    O=C(N1[C@H](C2=NC=C(C3=CC=C(C4=CC=C(C5=CN=C([C@H](CCC6)N6C(OC(C)(C)C)=O)N5)C=C4)C=C3)N2)CCC1)OC(C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Leclerc S, et al. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J Biol Chem. 2001 Jan 5;276(1):251-60.
molnova catalog
related products
  • TNF-α(71-82), human

    TNF-α(71-82), human

  • PACAP (1-38), human,...

    PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP), gastrin releasing peptide (GRP), and VIP release. PACAP 1-38 (10-8 M) inhibited gastrin secretion and stimulated somatostatin secretion and motility dose-dependently.

  • 2-Hydroxyemodin

    2-Hydroxyemodin is an active metabolite of emodin in the hepatic microsomes. Emodin is an anthraquinone present in fungal metabolites and constituent of rhubarb. 2-Hydroxyemodin proves to be mutagenic to Salmonella typhimurium TA1537 in the absence of activation system.